Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4594329

CIPAGLUCOSIDASE ALFA
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available

Basic Information

ChEMBL ID CHEMBL4594329
Name CIPAGLUCOSIDASE ALFA
Phase Approved
Structure Type SEQ
Therapeutic ✓ Yes

Known Names

AT GAA ATB-200 ATB200 Cipaglucosidase alfa Cipaglucosidase alfa-atga Pombiliti
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
6
Known Names
3
Indications
1
Mechanisms

Drug Information

Molecule Type Enzyme
First Approval 2023
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral

Flags

Black Box Warning
USAN Stem -ase
USAN Year 2019

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Glycogen hydrolytic enzyme HYDROLYTIC ENZYME Glycogen

Indications

Glycogen Storage Disease Type II Glycogen Storage Disease Type II Glycogen Storage Disease

ATC Classification

A16AB23
cipaglucosidase alfa
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

Drug Warnings

Black Box Warning
dermatological toxicity
Country: United States
Black Box Warning
respiratory toxicity
Country: United States
Black Box Warning
neurotoxicity
Country: United States

Data from ChEMBL 36 via Core Engine